First Midwest Bank Trust Division’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-34,313
Closed -$82K – 353
2020
Q3
$82K Sell
34,313
-54,111
-61% -$148K 0.01% 350
2020
Q2
$259K Sell
88,424
-71,288
-45% -$205K 0.04% 309
2020
Q1
$460K Buy
+159,712
New +$552K 0.08% 226

Other funds holding ADMA

First Midwest Bank Trust Division's ADMA Position: Q4 2020 in Review

First Midwest Bank Trust Division sold out of ADMA Biologics (ADMA) in Q4 2020, closing a stake of 34,313 shares — an estimated $82K sold.

First Midwest Bank Trust Division first reported a position in ADMA in Q1 2020 and held it in 3 quarters. The position peaked at $460K in Q1 2020. 95 funds tracked by Wall St. Rank hold ADMA as of Q4 2020.

  • First Midwest Bank Trust Division reported no remaining ADMA Biologics position as of Q4 2020 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 34,313 ADMA Biologics shares in Q4 2020, an estimated $82K.
  • First Midwest Bank Trust Division first reported a position in ADMA Biologics in Q1 2020 and held it in 3 quarters.
  • First Midwest Bank Trust Division's ADMA Biologics position peaked at $460K in Q1 2020.
  • 95 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2020.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2020, filed 14 Jan 2021.